News Release Details
Entegris Reports Results for Third Quarter of 2019
-
Third-quarter revenue of
$394.1 million , decreased 1% from prior year -
GAAP net income per diluted share of
$0.30 , decreased 12% from prior year -
Non-GAAP net income per diluted share of
$0.50 , increased 9% from prior year - Acquired Hangzhou Anow Microfiltration in September
Third-quarter sales were
Mr. Loy added: “Going forward, greater materials intensity and greater materials purity will continue to be the two defining factors of the next generation of semiconductor performance.
Quarterly Financial Results Summary
(in thousands, except per share data)
GAAP Results |
Q3 2019 |
Q3 2018 |
Q2 2019 |
|||
Net sales |
$394,147 |
$398,597 |
$378,874 |
|||
Operating income |
$52,793 |
$67,975 |
$54,909 |
|||
Operating margin |
13.4 |
% |
17.1 |
% |
14.5 |
% |
Net income |
$40,767 |
$48,060 |
$123,997 |
|||
Diluted earnings per share (EPS) |
$0.30 |
$0.34 |
$0.91 |
|||
Non-GAAP Results |
||||||
Non-GAAP adjusted operating income |
$88,220 |
$93,893 |
$76,793 |
|||
Non-GAAP adjusted operating margin |
22.4 |
% |
23.6 |
% |
20.3 |
% |
Non-GAAP net income |
$68,179 |
$65,621 |
$53,432 |
|||
Non-GAAP EPS |
$0.50 |
$0.46 |
$0.39 |
Fourth-Quarter Outlook
For the fourth quarter ending
Segment Results
The Company reports its results in the following segments:
Specialty Chemicals and Engineered Materials (SCEM): SCEM provides high-performance and high-purity process chemistries, gases and materials, as well as safe and efficient delivery systems to support semiconductor and other advanced manufacturing processes.
Microcontamination Control (MC): MC solutions purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries.
Advanced Materials Handling (AMH): AMH develops solutions to monitor, protect, transport, and deliver critical liquid chemistries, wafers, and substrates for a broad set of applications in the semiconductor industry and other high-technology industries.
Change in Inter-Segment Reporting
In the first quarter of 2019, the Company changed its definition of segment profit to include inter-segment sales. The Company updated its recognition of inter-segment sales to recognize the revenue and profit associated with products and components produced in one segment and supplied to another, before being sold to the ultimate end customer. The Company accounts for inter-segment sales and transfers as if the sales or transfers were to third parties, that is, at approximate market prices. Prior quarter information has been recast to reflect the change in the Company’s definition of segment profit.
Third-Quarter Results Conference Call Details
The call can also be accessed live and on-demand from the
Management’s slide presentation concerning the results for the third quarter, which may be referred to during the call, will be posted on the investor relations section of www.entegris.com Thursday morning before the call.
ABOUT
Non-GAAP Information
The Company’s condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include statements related to future period guidance; future sales, net income, net income per diluted share, non-GAAP EPS, non-GAAP net income, expenses and other financial metrics; the Company’s performance relative to its markets; the impact, financial or otherwise, of any organizational changes; market and technology trends; the development of new products and the success of their introductions; the Company's capital allocation strategy, which may be modified at any time for any reason, including share repurchases, dividends, debt repayments and potential acquisitions; the effect of the Tax Cuts and Jobs Act on the Company’s capital allocation strategy; the impact of the acquisitions the Company has made and commercial partnerships the Company has established; the Company’s ability to execute on its strategies; and other matters. These statements involve risks and uncertainties, and actual results may differ materially from those projected in the forward-looking statements. These risks and uncertainties include, but are not limited to, weakening of global and/or regional economic conditions, generally or specifically in the semiconductor industry, which could decrease the demand for the Company’s products and solutions; the Company’s ability to meet rapid demand shifts; the Company’s ability to continue technological innovation and introduce new products to meet customers' rapidly changing requirements; the Company’s concentrated customer base; the Company’s ability to identify, effect and integrate acquisitions, joint ventures or other transactions; the Company’s ability to effectively implement any organizational changes; the Company’s ability to protect and enforce intellectual property rights; operational, political and legal risks of the Company’s international operations; the Company’s dependence on sole source and limited source suppliers; the increasing complexity of certain manufacturing processes; raw material shortages, supply constraints and price increases; changes in government regulations of the countries in which the Company operates; fluctuation of currency exchange rates; fluctuations in the market price of the Company’s stock; the level of, and obligations associated with, the Company’s indebtedness; and other risk factors and additional information described in the Company’s filings with the
Condensed Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
|
|
Three months ended |
||||||||
|
|
September 28, 2019 |
September 29, 2018 |
June 29, 2019 |
||||||
Net sales |
$ |
394,147 |
|
$ |
398,597 |
|
$ |
378,874 |
|
|
Cost of sales |
223,797 |
|
216,881 |
|
212,600 |
|
||||
|
Gross profit |
170,350 |
|
181,716 |
|
166,274 |
|
|||
Selling, general and administrative expenses |
71,232 |
|
62,358 |
|
64,150 |
|
||||
Engineering, research and development expenses |
31,173 |
|
29,964 |
|
30,624 |
|
||||
Amortization of intangible assets |
15,152 |
|
21,419 |
|
16,591 |
|
||||
|
Operating income |
52,793 |
|
67,975 |
|
54,909 |
|
|||
Interest expense, net |
10,216 |
|
7,678 |
|
9,692 |
|
||||
Other expense (income), net |
934 |
|
810 |
|
(122,015 |
) |
||||
|
Income before income tax expense |
41,643 |
|
59,487 |
|
167,232 |
|
|||
Income tax expense |
876 |
|
11,427 |
|
43,235 |
|
||||
|
Net income |
$ |
40,767 |
|
$ |
48,060 |
|
$ |
123,997 |
|
|
|
|
|
|
||||||
|
|
|
||||||||
Basic net income per common share: |
$ |
0.30 |
|
$ |
0.34 |
|
$ |
0.92 |
|
|
Diluted net income per common share: |
$ |
0.30 |
|
$ |
0.34 |
|
$ |
0.91 |
|
|
|
|
|
|
|||||||
Weighted average shares outstanding: |
|
|
|
|||||||
|
Basic |
135,092 |
|
141,556 |
|
135,378 |
|
|||
|
Diluted |
136,530 |
|
143,033 |
|
136,581 |
|
Condensed Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
|
|
Nine months ended |
|||||
|
|
September 28, 2019 |
September 29, 2018 |
||||
Net sales |
$ |
1,164,068 |
|
$ |
1,148,855 |
|
|
Cost of sales |
650,051 |
|
608,764 |
|
|||
|
Gross profit |
514,017 |
|
540,091 |
|
||
Selling, general and administrative expenses |
217,636 |
|
185,827 |
|
|||
Engineering, research and development expenses |
90,788 |
|
87,781 |
|
|||
Amortization of intangible assets |
50,400 |
|
45,102 |
|
|||
|
Operating income |
155,193 |
|
221,381 |
|
||
Interest expense, net |
29,567 |
|
21,829 |
|
|||
Other (income) expense, net |
(121,329 |
) |
4,826 |
|
|||
|
Income before income tax expense |
246,955 |
|
194,726 |
|
||
Income tax expense |
49,533 |
|
34,755 |
|
|||
|
Net income |
$ |
197,422 |
|
$ |
159,971 |
|
|
|
|
|
||||
|
|
||||||
Basic net income per common share: |
$ |
1.46 |
|
$ |
1.13 |
|
|
Diluted net income per common share: |
$ |
1.45 |
|
$ |
1.12 |
|
|
|
|
|
|
||||
Weighted average shares outstanding: |
|
|
|||||
|
Basic |
135,256 |
|
141,613 |
|
||
|
Diluted |
136,601 |
|
143,308 |
|
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
|
September 28, 2019 |
December 31, 2018 |
||||
ASSETS |
|
|
||||
Cash and cash equivalents |
$ |
282,748 |
|
$ |
482,062 |
|
Trade accounts and notes receivable, net |
261,306 |
|
222,055 |
|
||
Inventories, net |
290,270 |
|
268,140 |
|
||
Deferred tax charges and refundable income taxes |
21,825 |
|
17,393 |
|
||
Other current assets |
28,091 |
|
39,688 |
|
||
Total current assets |
884,240 |
|
1,029,338 |
|
||
|
|
|
||||
Property, plant and equipment, net |
470,005 |
|
419,529 |
|
||
|
|
|
||||
Right-of-use assets |
48,684 |
|
— |
|
||
Goodwill |
659,840 |
|
550,202 |
|
||
Intangible assets |
367,558 |
|
295,687 |
|
||
Deferred tax assets and other noncurrent tax assets |
23,191 |
|
10,162 |
|
||
Other |
14,166 |
|
12,723 |
|
||
Total assets |
$ |
2,467,684 |
|
$ |
2,317,641 |
|
|
|
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|||||
Long-term debt, current maturities |
4,000 |
|
4,000 |
|
||
Accounts payable |
73,071 |
|
93,055 |
|
||
Accrued liabilities |
133,174 |
|
141,020 |
|
||
Income tax payable |
2,835 |
|
31,593 |
|
||
Total current liabilities |
213,080 |
|
269,668 |
|
||
|
|
|
||||
Long-term debt, excluding current maturities |
934,080 |
|
934,863 |
|
||
Long-term lease liability |
44,375 |
|
— |
|
||
Other liabilities |
156,232 |
|
101,085 |
|
||
Shareholders’ equity |
1,119,917 |
|
1,012,025 |
|
||
Total liabilities and shareholders’ equity |
$ |
2,467,684 |
|
$ |
2,317,641 |
|
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
|
Three months ended |
Nine months ended |
||||||||||
|
September 28,
|
September 29,
|
September 28,
|
September 29,
|
||||||||
Operating activities: |
|
|
|
|
||||||||
Net income |
$ |
40,767 |
|
$ |
48,060 |
|
$ |
197,422 |
|
$ |
159,971 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
||||||||
Depreciation |
19,306 |
|
16,537 |
|
54,623 |
|
48,236 |
|
||||
Amortization |
15,152 |
|
21,419 |
|
50,400 |
|
45,102 |
|
||||
Stock-based compensation expense |
5,326 |
|
4,170 |
|
14,915 |
|
12,727 |
|
||||
Other |
5,988 |
|
6,635 |
|
12,128 |
|
9,518 |
|
||||
Changes in operating assets and liabilities: |
|
|
|
|
||||||||
Trade accounts and notes receivable |
(35,841 |
) |
(11,400 |
) |
(30,405 |
) |
(8,713 |
) |
||||
Inventories |
(9,398 |
) |
(6,316 |
) |
(5,689 |
) |
(28,788 |
) |
||||
Accounts payable and accrued liabilities |
20,796 |
|
5,526 |
|
(31,911 |
) |
(9,440 |
) |
||||
Income taxes payable and refundable income taxes |
(35,965 |
) |
(1,678 |
) |
(20,574 |
) |
(9,193 |
) |
||||
Other |
(840 |
) |
1,190 |
|
12,745 |
|
1,829 |
|
||||
Net cash provided by operating activities |
25,291 |
|
84,143 |
|
253,654 |
|
221,249 |
|
||||
Investing activities: |
|
|
|
|
||||||||
Acquisition of property and equipment |
(26,322 |
) |
(27,900 |
) |
(86,423 |
) |
(75,337 |
) |
||||
Acquisition of businesses, net of cash acquired |
(217,106 |
) |
(43 |
) |
(266,373 |
) |
(380,268 |
) |
||||
Other |
2,618 |
|
3,109 |
|
2,815 |
|
5,014 |
|
||||
Net cash used in investing activities |
(240,810 |
) |
(24,834 |
) |
(349,981 |
) |
(450,591 |
) |
||||
Financing activities: |
|
|
|
|
||||||||
Payments on long-term debt |
— |
|
— |
|
(2,000 |
) |
(27,000 |
) |
||||
Issuance of common stock |
3,434 |
|
2 |
|
4,351 |
|
3,029 |
|
||||
Taxes paid related to net share settlement of equity awards |
(276 |
) |
(139 |
) |
(8,577 |
) |
(14,552 |
) |
||||
Repurchase and retirement of common stock |
(15,000 |
) |
(10,000 |
) |
(65,321 |
) |
(30,000 |
) |
||||
Dividend payments |
(10,815 |
) |
(9,899 |
) |
(29,779 |
) |
(29,701 |
) |
||||
Other |
(5 |
) |
(250 |
) |
(502 |
) |
1,254 |
|
||||
Net cash used in financing activities |
(22,662 |
) |
(20,286 |
) |
(101,828 |
) |
(96,970 |
) |
||||
Effect of exchange rate changes on cash |
(453 |
) |
(1,236 |
) |
(1,159 |
) |
(4,203 |
) |
||||
(Decrease) increase in cash and cash equivalents |
(238,634 |
) |
37,787 |
|
(199,314 |
) |
(330,515 |
) |
||||
Cash and cash equivalents at beginning of period |
521,382 |
|
257,106 |
|
482,062 |
|
625,408 |
|
||||
Cash and cash equivalents at end of period |
$ |
282,748 |
|
$ |
294,893 |
|
$ |
282,748 |
|
$ |
294,893 |
|
Segment Information
(In thousands)
(Unaudited)
Note: In the first quarter of 2019, the Company changed its definition of segment profit to include inter-segment sales. The Company updated its recognition of inter-segment sales to recognize the revenue and profit associated with products and components produced in one segment and supplied to another, before being sold to the ultimate end customer. The Company accounts for inter-segment sales and transfers as if the sales or transfers were to third parties, that is, at approximate market prices. Inter-segment sales are presented as an elimination below. Prior quarter information has been recast to reflect the change in the Company’s definition of segment profit.
|
Three months ended |
|
Nine months ended |
|||||||||||||
Net sales |
September 28,
|
September 29,
|
June 29, 2019 |
|
September 29, 2019 |
September 29, 2018 |
||||||||||
Specialty Chemicals and Engineered Materials |
$ |
127,750 |
|
$ |
131,234 |
|
$ |
127,552 |
|
|
$ |
379,772 |
|
$ |
396,313 |
|
Microcontamination Control |
155,979 |
|
151,478 |
|
150,185 |
|
|
463,870 |
|
395,338 |
|
|||||
Advanced Materials Handling |
117,256 |
|
123,227 |
|
107,515 |
|
|
340,835 |
|
377,877 |
|
|||||
Inter-segment elimination |
(6,838 |
) |
(7,342 |
) |
(6,378 |
) |
|
(20,409 |
) |
(20,673 |
) |
|||||
Total net sales |
$ |
394,147 |
|
$ |
398,597 |
|
$ |
378,874 |
|
|
$ |
1,164,068 |
|
$ |
1,148,855 |
|
|
Three months ended |
|
Nine months ended |
|||||||||||||
Segment profit |
September 28,
|
September 29,
|
June 29, 2019 |
|
September 28, 2019 |
September 29, 2018 |
||||||||||
Specialty Chemicals and Engineered Materials |
$ |
17,074 |
|
$ |
31,210 |
|
$ |
24,000 |
|
|
$ |
65,505 |
|
$ |
98,859 |
|
Microcontamination Control |
46,792 |
|
42,448 |
|
43,126 |
|
|
137,241 |
|
119,973 |
|
|||||
Advanced Materials Handling |
17,077 |
|
22,226 |
|
15,043 |
|
|
54,487 |
|
73,231 |
|
|||||
Total segment profit |
80,943 |
|
95,884 |
|
82,169 |
|
|
257,233 |
|
292,063 |
|
|||||
Amortization of intangible assets |
15,152 |
|
21,419 |
|
16,591 |
|
|
50,400 |
|
45,102 |
|
|||||
Unallocated expenses |
12,998 |
|
6,490 |
|
10,669 |
|
|
51,640 |
|
25,580 |
|
|||||
Total operating income |
$ |
52,793 |
|
$ |
67,975 |
|
$ |
54,909 |
|
|
$ |
155,193 |
|
$ |
221,381 |
|
Reconciliation of GAAP Gross Profit to Adjusted Gross Profit
(In thousands)
(Unaudited)
|
Three months ended |
|
Nine months ended |
|||||||||||||
|
September 28, 2019 |
September 29, 2018 |
June 29, 2019 |
|
September 28, 2019 |
September 29, 2018 |
||||||||||
Net sales |
$ |
394,147 |
|
$ |
398,597 |
|
$ |
378,874 |
|
|
$ |
1,164,068 |
|
$ |
1,148,855 |
|
Gross profit-GAAP |
$ |
170,350 |
|
$ |
181,716 |
|
$ |
166,274 |
|
|
$ |
514,017 |
|
$ |
540,091 |
|
Adjustments to gross profit: |
|
|
|
|
|
|
||||||||||
Severance and restructuring costs |
990 |
|
— |
|
— |
|
|
1,348 |
|
— |
|
|||||
Charge for fair value mark-up of acquired inventory sold |
4,483 |
|
3,281 |
|
695 |
|
|
7,333 |
|
3,489 |
|
|||||
Adjusted gross profit |
$ |
175,823 |
|
$ |
184,997 |
|
$ |
166,969 |
|
|
$ |
522,698 |
|
$ |
543,580 |
|
|
|
|
|
|
|
|
||||||||||
Gross margin - as a % of net sales |
43.2 |
% |
45.6 |
% |
43.9 |
% |
|
44.2 |
% |
47.0 |
% |
|||||
Adjusted gross margin - as a % of net sales |
44.6 |
% |
46.4 |
% |
44.1 |
% |
|
44.9 |
% |
47.3 |
% |
Reconciliation of GAAP Segment Profit to Adjusted Operating Income
(In thousands)
(Unaudited)
Note: In the first quarter of 2019, the Company changed its definition of segment profit to include inter-segment sales. The Company updated its recognition of inter-segment sales to recognize the revenue and profit associated with products and components produced in one segment and supplied to another, before being sold to the ultimate end customer. The Company accounts for inter-segment sales and transfers as if the sales or transfers were to third parties, that is, at approximate market prices. Prior quarter information has been recast to reflect the change in the Company’s definition of segment profit.
|
Three months ended |
|
Nine months ended |
|||||||||||||
Segment profit-GAAP |
September 28,
|
September 29,
|
June 29, 2019 |
|
September 28, 2019 |
September 29, 2018 |
||||||||||
Specialty Chemicals and Engineered Materials |
$ |
17,074 |
|
$ |
31,210 |
|
$ |
24,000 |
|
|
$ |
65,505 |
|
$ |
98,859 |
|
Microcontamination Control |
46,792 |
|
42,448 |
|
43,126 |
|
|
137,241 |
|
119,973 |
|
|||||
Advanced Materials Handling |
17,077 |
|
22,226 |
|
15,043 |
|
|
54,487 |
|
73,231 |
|
|||||
Total segment profit |
80,943 |
|
95,884 |
|
82,169 |
|
|
257,233 |
|
292,063 |
|
|||||
Amortization of intangible assets |
15,152 |
|
21,419 |
|
16,591 |
|
|
50,400 |
|
45,102 |
|
|||||
Unallocated expenses |
12,998 |
|
6,490 |
|
10,669 |
|
|
51,640 |
|
25,580 |
|
|||||
Total operating income |
$ |
52,793 |
|
$ |
67,975 |
|
$ |
54,909 |
|
|
$ |
155,193 |
|
$ |
221,381 |
|
|
Three months ended |
|
Nine months ended |
|||||||||||||
Adjusted segment profit |
September 28,
|
September 29,
|
June 29, 2019 |
|
September 28, 2019 |
September 29, 2018 |
||||||||||
Specialty Chemicals and Engineered Materials1 |
$ |
23,700 |
|
$ |
31,210 |
|
$ |
24,695 |
|
|
$ |
73,465 |
|
$ |
98,859 |
|
Microcontamination Control 2 |
49,769 |
|
45,729 |
|
43,126 |
|
|
142,977 |
|
123,462 |
|
|||||
Advanced Materials Handling 3 |
20,212 |
|
22,692 |
|
15,043 |
|
|
58,200 |
|
73,697 |
|
|||||
Total adjusted segment profit |
93,681 |
|
99,631 |
|
82,864 |
|
|
274,642 |
|
296,018 |
|
|||||
Adjusted amortization of intangible assets4 |
— |
|
— |
|
— |
|
|
— |
|
— |
|
|||||
Adjusted unallocated expenses5 |
5,461 |
|
5,738 |
|
6,071 |
|
|
17,449 |
|
18,510 |
|
|||||
Total adjusted operating income |
$ |
88,220 |
|
$ |
93,893 |
|
$ |
76,793 |
|
|
$ |
257,193 |
|
$ |
277,508 |
|
1 Adjusted segment profit for Specialty Chemicals and Engineered Materials for the three months ended
2 Adjusted segment profit for Microcontamination Control for the three and nine months ended
3Adjusted segment profit for Advanced Materials Handling for the three and nine months ended
4 Adjusted amortization of intangible assets excludes amortization expense of
5 Adjusted unallocated expenses for the three months ended
Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA
(In thousands)
(Unaudited)
|
Three months ended |
|
Nine months ended |
|||||||||||||
|
September 28, 2019 |
September 29, 2018 |
June 29, 2019 |
|
September 28, 2019 |
September 29, 2018 |
||||||||||
Net sales |
$ |
394,147 |
|
$ |
398,597 |
|
$ |
378,874 |
|
|
$ |
1,164,068 |
|
$ |
1,148,855 |
|
Net income |
$ |
40,767 |
|
$ |
48,060 |
|
$ |
123,997 |
|
|
$ |
197,422 |
|
$ |
159,971 |
|
Adjustments to net income: |
|
|
|
|
|
|
||||||||||
Income tax expense |
876 |
|
11,427 |
|
43,235 |
|
|
49,533 |
|
34,755 |
|
|||||
Interest expense, net |
10,216 |
|
7,678 |
|
9,692 |
|
|
29,567 |
|
21,829 |
|
|||||
Other expense (income), net |
934 |
|
810 |
|
(122,015 |
) |
|
(121,329 |
) |
4,826 |
|
|||||
GAAP - Operating income |
52,793 |
|
67,975 |
|
54,909 |
|
|
155,193 |
|
221,381 |
|
|||||
Charge for fair value write-up of acquired inventory sold |
4,483 |
|
3,281 |
|
695 |
|
|
7,333 |
|
3,489 |
|
|||||
Deal costs |
4,891 |
|
— |
|
1,164 |
|
|
25,191 |
|
5,121 |
|
|||||
Integration costs |
2,398 |
|
752 |
|
1,264 |
|
|
6,582 |
|
1,949 |
|
|||||
Severance and restructuring costs |
8,503 |
|
— |
|
2,170 |
|
|
12,494 |
|
— |
|
|||||
Loss on sale of subsidiary |
— |
|
466 |
|
— |
|
|
— |
|
466 |
|
|||||
Amortization of intangible assets |
15,152 |
|
21,419 |
|
16,591 |
|
|
50,400 |
|
45,102 |
|
|||||
Adjusted operating income |
88,220 |
|
93,893 |
|
76,793 |
|
|
257,193 |
|
277,508 |
|
|||||
Depreciation |
19,306 |
|
16,537 |
|
18,596 |
|
|
54,623 |
|
48,236 |
|
|||||
Adjusted EBITDA |
$ |
107,526 |
|
$ |
110,430 |
|
$ |
95,389 |
|
|
$ |
311,816 |
|
$ |
325,744 |
|
|
|
|
|
|
|
|
||||||||||
Net income - as a % of net sales |
10.3 |
% |
12.1 |
% |
32.7 |
% |
|
17.0 |
% |
13.9 |
% |
|||||
Adjusted operating margin |
22.4 |
% |
23.6 |
% |
20.3 |
% |
|
22.1 |
% |
24.2 |
% |
|||||
Adjusted EBITDA - as a % of net sales |
27.3 |
% |
27.7 |
% |
25.2 |
% |
|
26.8 |
% |
28.4 |
% |
Reconciliation of GAAP Net Income and Earnings per Share to Non-GAAP Net Income and Earnings per Share
(In thousands, except per share data)
(Unaudited)
|
Three months ended |
|
Nine months ended |
|||||||||||||
|
September 28, 2019 |
September 29, 2018 |
June 29, 2019 |
|
September 28,
|
September 29,
|
||||||||||
GAAP net income |
$ |
40,767 |
|
$ |
48,060 |
|
$ |
123,997 |
|
|
$ |
197,422 |
|
$ |
159,971 |
|
Adjustments to net income: |
|
|
|
|
|
|
||||||||||
Charge for fair value write-up of acquired inventory sold |
4,483 |
|
3,281 |
|
695 |
|
|
7,333 |
|
3,489 |
|
|||||
Deal costs |
4,891 |
|
— |
|
1,164 |
|
|
25,602 |
|
5,121 |
|
|||||
Integration costs |
2,398 |
|
752 |
|
1,264 |
|
|
6,582 |
|
1,949 |
|
|||||
Severance and restructuring costs |
8,503 |
|
— |
|
2,170 |
|
|
12,494 |
|
— |
|
|||||
Versum termination fee, net |
— |
|
— |
|
(122,000 |
) |
|
(122,000 |
) |
— |
|
|||||
Loss on sale of subsidiary |
— |
|
466 |
|
— |
|
|
— |
|
466 |
|
|||||
Amortization of intangible assets |
15,152 |
|
21,419 |
|
16,591 |
|
|
50,400 |
|
45,102 |
|
|||||
Tax effect of legal entity restructuring |
— |
|
— |
|
9,398 |
|
|
9,398 |
|
— |
|
|||||
Tax effect of adjustments to net income and discrete items1 |
(8,015 |
) |
(5,797 |
) |
20,153 |
|
|
2,274 |
|
(12,209 |
) |
|||||
Tax effect of Tax Cuts and Jobs Act |
— |
|
(2,560 |
) |
— |
|
|
— |
|
(418 |
) |
|||||
Non-GAAP net income |
$ |
68,179 |
|
$ |
65,621 |
|
$ |
53,432 |
|
|
$ |
189,505 |
|
$ |
203,471 |
|
|
|
|
|
|
|
|
||||||||||
Diluted earnings per common share |
$ |
0.30 |
|
$ |
0.34 |
|
$ |
0.91 |
|
|
$ |
1.45 |
|
$ |
1.12 |
|
Effect of adjustments to net income |
$ |
0.20 |
|
$ |
0.12 |
|
$ |
(0.52 |
) |
|
$ |
(0.06 |
) |
$ |
0.30 |
|
Diluted non-GAAP earnings per common share |
$ |
0.50 |
|
$ |
0.46 |
|
$ |
0.39 |
|
|
$ |
1.39 |
|
$ |
1.42 |
|
1The tax effect of pre-tax adjustments to net income was calculated using the applicable marginal tax rate during the respective years.
Reconciliation of GAAP Outlook to Non-GAAP Outlook
(In millions, except per share data)
(Unaudited)
|
Fourth-Quarter Outlook |
|
Reconciliation GAAP net income to non-GAAP net income |
December 31, 2019 |
|
GAAP net income |
$51 - $58 |
|
Adjustments to net income: |
|
|
Charge for fair value write-up of acquired inventory sold |
5 |
|
Restructuring and integration costs |
2 |
|
Amortization of intangible assets |
17 |
|
Income tax effect |
(6) |
|
Non-GAAP net income |
$69 - $76 |
|
Fourth-Quarter Outlook |
|
Reconciliation GAAP diluted earnings per share to non-GAAP diluted earnings per share |
December 31, 2019 |
|
Diluted earnings per common share |
$0.38 - $0.43 |
|
Adjustments to diluted earnings per common share: |
|
|
Charge for fair value write-up of acquired inventory sold |
0.03 |
|
Restructuring and integration costs |
0.01 |
|
Amortization of intangible assets |
0.13 |
|
Income tax effect |
(0.04) |
|
Diluted non-GAAP earnings per common share |
$0.51 to $0.56 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20191024005182/en/
Source:
Bill Seymour
VP of Investor Relations
T + 1 952 556 1844